Lafutidine, a unique histamine H2-receptor antagonist, inhibits distention-induced gastric acid secretion through an H2 receptor-independent mechanism

European Journal of Pharmacology

Volumn 658, Issue 2-3, 2011, Pages 236-241

  Nakano, Motoko ^a   Kitano, Shizuo ^a   Nanri, Masato ^a   Kiniwa, Mamoru ^a  

^a TAIHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

Carbachol; Distention; Gastric acid secretion; Histamine H2 receptor antagonist; Lafutidine; Nitric oxide

Indexed keywords

ATROPINE; CAPSAICIN; CAPSAZEPINE; CARBACHOL; CIMETIDINE; FAMOTIDINE; HISTAMINE H2 RECEPTOR; LAFUTIDINE; LANSOPRAZOLE; N(G) METHYLARGININE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; STOMACH ACID SECRETION; STOMACH DISTENSION; VAGOTOMY;

ACETAMIDES; ANIMALS; GASTRIC ACID; HISTAMINE H2 ANTAGONISTS; MALE; NITRIC OXIDE; PIPERIDINES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, HISTAMINE H2; STOMACH;

EID: 79953792091     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.02.007     Document Type: Article

References (26)

1. Berg, A., Redéen, S., Grenegård, M., Ericson, A.C., Sjöstrand, S.E., 2005. Nitric oxide inhibits gastric acid secretion by increasing intraparietal cell levels of cGMP in isolated human gastric glands. Am. J. Physiol. Gastrointest. Liver Physiol. 289, G1061-G1066.
2. 2-receptor blockade on vagally induced gastric secretion in man. Br. Med. J. 3, 554-556.
3. Edelsbrunner, M.E., Nakano, M., Holzer, P., 2009. Afferent signalling from the acid-challenged rat stomach is inhibited and gastric acid elimination is enhanced by lafutidine. BMC Gastroenterol. 9, 40.
4. Fukushima, K., Aoi, Y., Kato, S., Takeuchi, K., 2006. Gastro-protective action of lafutidine mediated by capsaicin-sensitive afferent neurons without interaction with TRPV1 and involvement of endogenous prostaglandins. World J. Gastroenterol. 12, 3031-3037.
5. Hasebe, K., Horie, S., Noji, T., Watanabe, K., Yano, S., 2005. Stimulatory effects of endogenous and exogenous nitric oxide on gastric acid secretion in anesthetized rats. Nitric Oxide 13, 264-271. (Pubitemid 41572289)
6. Ichikawa, T., Ishihara, K., Saigenji, K., Hotta, K., 1994. Effects of acid-inhibitory antiulcer drugs on mucin biosynthesis in the rat stomach. Eur. J. Pharmacol. 251, 107-111.
7. Ichikawa, T., Ishihara, K., Shibata, M., Yamaura, T., Saigenji, K., Hotta, K., 1996. Stimulation of mucin biosynthesis in rat gastric mucosa by FRG-8813 and its structural analogs. Eur. J. Pharmacol. 297, 87-92.
8. Ichikawa, T., Ishihara, K., Saigenji, K., Hotta, K., 1998. Lafutidine-induced stimulation of mucin biosynthesis mediated by nitric oxide is limited to the surface mucous cells of rat gastric oxyntic mucosa. Life Sci. 62, 259-264.
9. 2-receptor antagonist, lafutidine, on the mucus barrier of human gastric mucosa. J. Gastroenterol. Hepatol. 22, 1800-1805.
10. 2-receptor antagonists with gastric mucosal defensive properties. Mini-Rev. Med. Chem 9, 581-589.
11. 2-receptor antagonistic property of FRG-8813, a novel antiulcer drug. Folia Pharmacol. Jpn. 105, 231-241.
12. Inamori, M., Togawa, J., Iwasaki, T., Ozawa, Y., Kikuchi, T., Muramatsu, K., Chiguchi, G., Matsumoto, S., Kawamura, H., Abe, Y., Kirikoshi, H., Kobayashi, N., Shimamura, T., Kubota, K., Sakaguchi, T., Saito, S., Ueno, N., Nakajima, A., 2005. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use. J. Gastroenterol. 40, 453-458. (Pubitemid 40823279)
13. Kato, S., Tanaka, A., Kunikata, T., Umeda, M., Takeuchi, K., 2000. Protective effect of lafutidine against indomethacin-induced intestinal ulceration in rats: relation to capsaicin-sensitive sensory neurons. Digestion 61, 39-46. (Pubitemid 30098957)
14. Kitamura, M., Sugamoto, S., Kawauchi, S., Kato, S., Takeuchi, K., 1999. Modulation by endogenous nitric oxide of acid secretion induced by gastric distention in rats: enhancement by nitric oxide synthase inhibitor. J. Pharmacol. Exp. Ther. 291, 181-187.
15. Martinez, F.E., Harabor, A., Amankwah, E.K., Hart, D.A., Belik, J., 2000. Urethane suppresses rat lung inducible cyclooxygenase and nitric oxide synthase mRNA levels. Inflamm. Res. 49, 727-731.
16. 2-receptor antagonist, on reflux esophagitis in rats through capsaicin-sensitive afferent neurons. J. Pharmacol. Sci. 93, 55-61.
17. Nishihara, K., Nozawa, Y., Nakano, M., Ajioka, H., Matsuura, N., 2002. Sensitizing effects of lafutidine onCGRP-containing afferent nerves in the rat stomach. Br. J. Pharmacol. 135, 1487-1494.
18. Noto, T., Nagasaki, M., Endo, T., 1997. Role of vagus nerves and gastrin in the gastric phase of acid secretion in male anesthetized rats. Am. J. Physiol. 272, G335-G339.
19. 2-receptor antagonist, on dextran sulfate sodium-induced colonic inflammation through capsaicin-sensitive afferent neurons in rats. Dig. Dis. Sci. 49, 1696-1704.
20. 2-receptor antagonist, in rats. Jpn J. Pharmacol. 68, 161-173.
21. 2-receptor antagonistic activity. Arzneimittelforschung 49, 519-526.
22. Saegusa, Y., Ichikawa, T., Iwai, T., Goso, Y., Ikezawa, T., Nakano, M., Shikama, N., Saigenji, K., Ishihara, K., 2008. Effects of acid antisecretory drugs on mucus barrier of the rat against 5-fluorouracil-induced gastrointestinal mucositis. Scand. J. Gastroenterol. 43, 531-537.
23. 2 receptor antagonist, in rats and dogs. Eur. J. Pharmacol. 235, 245-253.
24. Takeuchi, K., Matsumoto, J., Ueshima, K., Okabe, S., 1991. Role of capsaicin-sensitive afferent neurons in alkaline secretory response to luminal acid in the rat duodenum. Gastroenterology 101, 954-961.
25. Tanaka, S., Hamada, K., Yamada, N., Sugita, Y., Tonai, S., Hunyady, B., Palkovits, M., Falus, A., Watanabe, T., Okabe, S., Ohtsu, H., Ichikawa, A., Nagy, A., 2002. Gastric acid secretion in L-histidine decarboxylase-deficient mice. Gastroenterology 122, 145-155. (Pubitemid 34049203)
26. 2 receptor antagonist, than by the proton pump inhibitor lansoprazole. World J. Gastroenterol. 14, 2406-2410.